Farrell Michael J. 4
4 · RESMED INC · Filed Nov 13, 2025
Insider Transaction Report
Form 4
RESMED INCRMD
Farrell Michael J.
DirectorChairman and CEO
Transactions
- Tax Payment
ResMed Common Stock
2025-11-11$250.10/sh−2,231.545$558,109→ 465,634 total - Tax Payment
ResMed Common Stock
2025-11-11$250.10/sh−3,459.325$865,177→ 462,175 total - Tax Payment
ResMed Common Stock
2025-11-11$250.10/sh−2,205.697$551,645→ 459,969 total
Holdings
- 2,090(indirect: By Trust)
ResMed Common Stock
Footnotes (3)
- [F1]Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022.
- [F2]Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2023.
- [F3]Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2024.